ARWR vs AMGN: Which Stock is Better?
Side-by-side comparison of Arrowhead Pharmaceuticals Inc and Amgen Inc in 2026
ARWR
Arrowhead Pharmaceuticals Inc
$70.53
AMGN
Amgen Inc
$338.02
Key Metrics Comparison
| Metric | ARWR | AMGN | Winner |
|---|---|---|---|
| Market Cap | $9.82B | $183.05B | AMGN |
| P/E Ratio | 43.83 | 23.86 | AMGN |
| EPS (TTM) | $1.60 | $14.23 | AMGN |
| Revenue Growth | 104.6% | 0.1% | ARWR |
| Gross Margin | 100.0% | 70.8% | ARWR |
Analyze ARWR
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARWR or AMGN a better investment?
Comparing ARWR and AMGN: Arrowhead Pharmaceuticals Inc has a market cap of $9.82B while Amgen Inc has $183.05B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARWR and AMGN?
ARWR (Arrowhead Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARWR or AMGN?
Based on P/E ratios, AMGN trades at a lower multiple (23.9x vs 43.8x).
Which is growing faster: ARWR or AMGN?
ARWR has higher revenue growth at 104.6% vs 0.1% for AMGN.
Which company is more profitable: ARWR or AMGN?
Arrowhead Pharmaceuticals Inc (ARWR) has higher gross margins at 100.0% compared to 70.8% for AMGN.
Which is the larger company: ARWR or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $183.05B compared to $9.82B for ARWR.
Should I buy ARWR or AMGN in 2026?
Both ARWR and AMGN have investment merit. ARWR trades at $70.53 while AMGN trades at $338.02. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARWR and AMGN stock?
Key differences: Market Cap ($9.82B vs $183.05B), P/E Ratio (43.8x vs 23.9x), Revenue Growth (104.6% vs 0.1%), Gross Margin (100.0% vs 70.8%).